Oliver Lagore Vanvalin Investment Group Exact Sciences Corp Transaction History
Oliver Lagore Vanvalin Investment Group
- $359 Million
- Q3 2024
A detailed history of Oliver Lagore Vanvalin Investment Group transactions in Exact Sciences Corp stock. As of the latest transaction made, Oliver Lagore Vanvalin Investment Group holds 50 shares of EXAS stock, worth $2,183. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50
Previous 50
-0.0%
Holding current value
$2,183
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding EXAS
# of Institutions
672Shares Held
152MCall Options Held
4.25MPut Options Held
1.89M-
Capital World Investors Los Angeles, CA17.5MShares$766 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA17MShares$743 Million0.02% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$527 Million0.01% of portfolio
-
State Street Corp Boston, MA6.23MShares$272 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.76MShares$251 Million0.04% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $7.73B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...